GGrantIndex
Sort

64,565 grants matching drug discovery

Development and Validation of a CNS Organoid Model of Temporal Lobe Epilepsy for Drug Discovery

$499,953
Connie S Lebakken · Stem Pharm, Inc. · R43 · FY2024 · NS

Machine Learning Phenotypic De Novo Drug Design

$499,946
Daniela Brunner · Psychogenics, Inc. · R43 · FY2024 · MH

Machine Learning Phenotypic De Novo Drug Design

$499,946
Daniela Brunner · Psychogenics, Inc. · R43 · FY2023 · MH

Genetic/Epigenetic Markers, Social Contexts, Lifecourse and Risky Health Behavior

$499,940
Guang Guo · Univ Of North Carolina Chapel Hill · RC1 · FY2010 · DA

PET Imaging Agent for Diabetes Mellitus

$499,937
Jogesh Mukherjee · University Of California-Irvine · RC1 · FY2010 · DK

Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni

$499,926
Asim B Abdel-Mageed · Tulane University Of Louisiana · UH2 · FY2013 · TR

Neuroprotective Engineering Based on Innate Responses to Stroke

$499,922
Shu Q Liu · Northwestern University · · FY2014 · ENG

CCRI: ENS: Collaborative Research: Open Computer System Usage Repository and Analytics Engine

$499,920
Stephen L Harrell · University Of Texas At Austin · · FY2020 · CSE

Orally Active Nucleoside Phosphonates for Hepatitis C Virus

$499,920
Robert Turner Schooley · University Of California, San Diego · R01 · FY2013 · AI

Human Neural Organoid Modeling of Alzheimer's Disease Neuroinflammation for Drug Discovery

$499,903
Connie S Lebakken · Stem Pharm, Inc. · R43 · FY2023 · AG

NSAID-Phosphatidylcholine Association: Insight in GI Ulcer Pathogenesis/Therapy

$499,896
Lenard M Lichtenberger · University Of Texas Hlth Sci Ctr Houston · RC1 · FY2010 · DK

Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease

$499,889
Lynda Stuart · Benaroya Research Inst At Virginia Mason · R33 · FY2015 · AI

Development of Small-Molecule Degraders of APP as the first-in-class drugs for Alzheimer's therapy

$499,883
Chunhai Charlie Hao · Degrome Therapeutics, Inc. · R41 · FY2024 · AG

SBIR Phase II: An Innovative Full-Thickness Human Skin Model for Increased Throughput Screening in Drug Discovery

$499,877
Kenneth R Gratz · Stratatech Corporation · · FY2011 · TIP

Collaborative Research: EDGE FGT: Functional Genomic Tools for Parasitic Nematodes and their Bacterial Symbionts

$499,872
Paul W Sternberg · California Institute Of Technology · · FY2021 · BIO

Leads and Target Validation for Vascular Calcification in Chronic Kidney Disease

$499,870
Jose Luis Millan · Sanford Burnham Prebys Medical Discovery Institute · RC1 · FY2009 · HL

Characterization of a Treatment-Response Biomarker in Patients with Schizophrenia

$499,868
Judith Morse Gault · University Of Colorado Denver · RC1 · FY2010 · MH

Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain

$499,863
Christopher Dockendorff · Function Therapeutics, Inc. · R43 · FY2025 · NS

Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib

$499,850
Richard W Scott · Polymedix, Inc, · R44 · FY2010 · AI

MOLECULAR BASIS OF VESTIBULAR EFFERENT FUNCTION

$499,841
P. Ashley Wackym · Medical College Of Wisconsin · R01 · FY2007 · DC

CICI:SIVD:Context-Aware Vulnerability Detection in Configurable Scientific Computing Environments

$499,834
Mu Zhang · University Of Utah · · FY2021 · CSE

Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease

$499,828
Luana Fioriti · Nanonewron Llc · R41 · FY2023 · AG

Discovery of 4-aminoquinoline therapeutics for visceral leishmaniasis

$499,826
Peter C. Melby · University Of Texas Med Br Galveston · RC1 · FY2010 · AI

SBIR Phase II: Bioinformatics knowledge-based, universal library design for a non-immunoglobulin, protein-scaffold

$499,825
Guido Cappuccilli · Protelix Inc · · FY2009 · TIP

SBIR Phase II: In vivo Fluorescence Imaging Kit for Cell Proliferation.

$499,824
Maryana Breitman · Mbmr Biolabs Inc. · · FY2012 · TIP